Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App




New Clinical Chemistry Analyzer Introduced at Medica 2015

By LabMedica International staff writers
Posted on 22 Nov 2015
A new state-of-the-art clinical chemistry analyzer has been unveiled at the Düsseldorf (Germany), Medica 2015 biomedical instrumentation fair.

This year's fair, which was held during November 16–19, 2015, saw the introduction of the EKF Diagnostics (Cardiff, United Kingdom) Altair 240 clinical chemistry analyzer.

This new bench-top platform represents EKF Diagnostics’ first fully integrated chemistry system designed for the global market. More...
EKF believes that the new Altair 240 clinical chemistry analyzer fulfills an international market need for a fully automated bench-top platform supported by Stanbio Chemistry (Boerne, TX, USA) reagent menu.

The new analyzer is highly efficient, as it can run up to 400 tests per hour with an optional ISE module. Dual reagent probes translate to higher throughput and faster patient turn-around times. Operating cost efficiencies are also realized through an integrated cuvette washing station, enabling the reuse of cuvettes; as well as continual 24-hour on-board cooling, which ensures most reagents have a 30-day on board stability to minimize waste.

“We listened to the needs of our customers and designed the Altair 240 to be easy to learn, operate, and maintain,” said Albert Blanco, business unit director at EKF Diagnostics. “Because it runs on Windows 7, operators can easily navigate its intuitive, touch screen menu. Innovative features such as the capability to use barcoded primary sample tubes, auto-rerun, auto-dilution, and STAT interruption, all function to maximize the system’s overall efficiency.”

EKF also discussed the latest additions to its Stanbio clinical chemistry range. This range includes a large selection of clinical chemistry assays, controls, and calibrators, which are fully compatible with most major brand open channel chemistry analyzers.

In addition, EKF exhibited its full range of POC (point-of-care) blood analyzers. This comprehensive range includes hemoglobin analyzers, lactate analyzers, glucose testing, and HbA1c analyzers. All are simple to use and designed to quickly deliver accurate results to aid the diagnosis of anemia, diabetes and associated conditions.

Related Links:

EKF Diagnostics
Stanbio Chemistry



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.